Oncolytic Virus Therapy Market Investment Trends and Strategic Partnerships
Investment activity in the oncolytic virus therapy market has reached substantial levels as venture capital firms, pharmaceutical companies, and government agencies commit significant resources to platform development, clinical trials, and manufacturing infrastructure. The market has attracted over USD 4.2 billion in cumulative investment since 2020, with Bristol Myers Squibb's USD 3.6 billion...
0 Commenti 0 condivisioni 11 Views 0 Anteprima